Promising prostate cancer treatment trial halted early
NCT ID NCT04876651
First seen Mar 03, 2026 · Last updated May 19, 2026 · Updated 10 times
Summary
This study tested a new drug (177Lu-DOTA-rosopatamab) that delivers radiation directly to prostate cancer cells. It was for men with advanced prostate cancer that had stopped responding to hormone therapy. The trial aimed to see if adding this drug to standard care could slow cancer growth better than standard care alone. However, the study was terminated early after enrolling only 16 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
'GenesisCare Murdoch'
Murdoch, Western Australia, 6150, Australia
-
Auckland City Hospital
Auckland, 1023, New Zealand
-
Austin Health
Melbourne, Victoria, 3083, Australia
-
Monash Health
Clayton, Victoria, 3168, Australia
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
-
Westmead Hospital
Westmead, New South Wales, 2145, Australia
Conditions
Explore the condition pages connected to this study.